Nano Pharmasolutions

Executive Summary

Nano PharmaSolutions is a private San Diego-based biotechnology company founded in 2014, specializing in nanotechnology-based drug delivery systems. Its core platform, NanoTransformer®, enhances the solubility and bioavailability of poorly soluble compounds. The company has developed a specialized CNS delivery system, Nano-CNS®, which enables nose-to-brain administration of neurotherapeutics, potentially overcoming the blood-brain barrier. Despite limited public data and no disclosed funding rounds, the company's focus on high-value CNS indications and its proprietary technology position it as an attractive candidate for strategic partnerships or licensing deals. The company is in a pre-revenue stage, with its progress dependent on advancing preclinical candidates and securing collaborations.

Upcoming Catalysts (preview)

• Q4 2026Preclinical advancement of Nano-CNS platform30% success
• TBDStrategic partnership or licensing deal for CNS delivery40% success
• Q2 2026Research collaboration with academic or pharma partners20% success